Johnson Fistel Probes Aspen Aerogels Over $291M Impairment Charge

GlobeNewswire Inc.GlobeNewswire Inc.
|||1 min read
Key Takeaway

Law firm Johnson Fistel investigates Aspen Aerogels over $291M impairment charge, alleging potential securities fraud and misrepresentations regarding asset valuations.

Johnson Fistel Probes Aspen Aerogels Over $291M Impairment Charge

Law firm Johnson Fistel, PLLC has initiated an investigation into potential securities fraud claims affecting Aspen Aerogels, Inc. shareholders. The inquiry was prompted by the company's announcement on February 25, 2026, regarding a $291.2 million impairment charge associated with its Statesboro manufacturing facility. The disclosure resulted in a material decline in the company's share price, triggering shareholder concerns about potential misrepresentations or omissions related to asset valuations.

The impairment charge represents a significant write-down that raises questions about the company's prior representations regarding the facility's value and operational prospects. Shareholders who sustained losses following the announcement are being encouraged to contact the firm to discuss potential recovery options. The investigation examines whether company officials possessed material information regarding asset impairment prior to public disclosure.

Johnson Fistel is simultaneously investigating securities claims against two other publicly traded companies: Driven Brands Holdings and Oddity Tech Ltd. Investors in Aspen Aerogels seeking additional information about the investigation or potential claims are advised to reach out to the firm directly for case evaluation and representation details.

Source: GlobeNewswire Inc.

Back to newsPublished Feb 25

Related Coverage

GlobeNewswire Inc.

ImmunityBio Stock Plummets 21% After FDA Warning Over Anktiva Cancer Claims

ImmunityBio faces securities fraud lawsuit after FDA warning letter alleges false Anktiva promotional claims. Stock dropped 21% to $7.42.

IBRX
GlobeNewswire Inc.

Driven Brands Faces Class Action Over Accounting Misstatements and Control Failures

Class action filed against $DRVN alleging materially false financial statements, weak internal controls, and unreconciled 2023 cash balance inflating revenues.

DRVN
GlobeNewswire Inc.

Stellantis Faces Securities Lawsuit Over €22B Charge; Investor Deadline Looms

The Gross Law Firm announced securities class action against $STLA for allegedly misleading investors on earnings and EV capabilities, triggering 23.69% stock decline.

STLALUPOET
GlobeNewswire Inc.

DRVN Investors Face May 8 Deadline in Securities Fraud Class Action

Driven Brands investors face May 8, 2026 deadline to join securities fraud class action alleging false financial statements and undisclosed control weaknesses.

DRVN
GlobeNewswire Inc.

Oddity Tech Faces Securities Lawsuit Over Algorithm Changes, May 11 Deadline Looms

Securities class action filed against $ODD alleges misleading statements about algorithm changes that increased customer acquisition costs. Investors have until May 11, 2026 to secure counsel.

ODD
GlobeNewswire Inc.

MRBK Stock Plunges 8.9% as Fraud Investigation Launched Into Meridian Corporation

Schall Law Firm investigates $MRBK for securities violations after stock dropped 8.9% following earnings miss tied to SBA loan portfolio deterioration.

MRBK